← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 28, 2017Last known activity
Sep 20, 2021
Timeline
2010s
- Jun 1, 2011
Vigeo Therapeutics, Inc.— Founded
Drugs by trial phase (8 distinct, 3 trials)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT05039177Study directorPhase 1/Phase 2Sep 20, 2021
- NCT04959981Study directorPhase 1/Phase 2Sep 2, 2021
- NCT03364400Study directorPhase 1Nov 28, 2017
- NCT03364400Lead sponsorPhase 1Nov 28, 2017
Details
- Founded
- Cambridge, MA, US Jun 1, 2011
- Last known activity
- Sep 20, 2021